A high-throughput \u3ci\u3ede novo\u3c/i\u3e sequencing approach for shotgun proteomics using high-resolution tandem mass spectrometry by Pan, Chongle et al.
University of Tennessee, Knoxville
Trace: Tennessee Research and Creative
Exchange
EECS Publications and Other Works Electrical Engineering and Computer Science
3-5-2010
A high-throughput de novo sequencing approach for
shotgun proteomics using high-resolution tandem
mass spectrometry
Chongle Pan
Oak Ridge National Laboratory
Byung H. Park
Oak Ridge National Laboratory
William H. McDonald
Vanderbilt University
Patricia A. Carey
University of Tennessee - Knoxville, carey@cs.utk.edu
Jillian F. Banfield
University of California - Berkeley
See next page for additional authors
Follow this and additional works at: http://trace.tennessee.edu/utk_elecpubs
Part of the Computer Sciences Commons
This Article is brought to you for free and open access by the Electrical Engineering and Computer Science at Trace: Tennessee Research and Creative
Exchange. It has been accepted for inclusion in EECS Publications and Other Works by an authorized administrator of Trace: Tennessee Research and
Creative Exchange. For more information, please contact trace@utk.edu.
Recommended Citation
BMC Bioinformatics 2010, 11:118 doi:10.1186/1471-2105-11-118
Authors
Chongle Pan, Byung H. Park, William H. McDonald, Patricia A. Carey, Jillian F. Banfield, Nathan C.
VerBerkmoes, Robert L. Hettich, and Nagiza F. Samatova
This article is available at Trace: Tennessee Research and Creative Exchange: http://trace.tennessee.edu/utk_elecpubs/14
RESEARCH ARTICLE Open Access
A high-throughput de novo sequencing approach
for shotgun proteomics using high-resolution
tandem mass spectrometry
Chongle Pan1,2*, Byung H Park1, William H McDonald2,6, Patricia A Carey5, Jillian F Banfield4,
Nathan C VerBerkmoes2, Robert L Hettich2*, Nagiza F Samatova1,3*
Abstract
Background: High-resolution tandem mass spectra can now be readily acquired with hybrid instruments, such as
LTQ-Orbitrap and LTQ-FT, in high-throughput shotgun proteomics workflows. The improved spectral quality
enables more accurate de novo sequencing for identification of post-translational modifications and amino acid
polymorphisms.
Results: In this study, a new de novo sequencing algorithm, called Vonode, has been developed specifically for
analysis of such high-resolution tandem mass spectra. To fully exploit the high mass accuracy of these spectra, a
unique scoring system is proposed to evaluate sequence tags based primarily on mass accuracy information of
fragment ions. Consensus sequence tags were inferred for 11,422 spectra with an average peptide length of 5.5
residues from a total of 40,297 input spectra acquired in a 24-hour proteomics measurement of
Rhodopseudomonas palustris. The accuracy of inferred consensus sequence tags was 84%. According to our
comparison, the performance of Vonode was shown to be superior to the PepNovo v2.0 algorithm, in terms of the
number of de novo sequenced spectra and the sequencing accuracy.
Conclusions: Here, we improved de novo sequencing performance by developing a new algorithm specifically for
high-resolution tandem mass spectral data. The Vonode algorithm is freely available for download at http://
compbio.ornl.gov/Vonode.
Background
Tandem mass spectrometry (MS/MS) has become an
important method for characterizing complex protein
mixtures. Since the emergence of this high-throughput
technology, two complementary data analysis
approaches have been pursued: a database searching
approach and a de novo sequencing approach. The for-
mer identifies peptide sequences from a protein data-
base by matching their predicted tandem mass spectra
to measured tandem mass spectra; whereas the latter
infers partial or complete peptide sequences directly
from measured tandem mass spectra. Due to its high
identification accuracy and the rapid expansion of
genomic sequence data, the database searching
approach, enabled by popular algorithms such as
Sequest [1] and Mascot [2], is routinely used in current
proteomics workflows. In contrast, although many de
novo algorithms have been developed [3-14], they have
not been widely used in high-throughput proteomics
workflows. A high-throughput de novo sequencing cap-
ability is critically needed for detection of post-transla-
tional modifications (PTMs), characterization of amino
acid polymorphisms, and identification of proteins not
represented in sequence databases.
De novo sequencing has been actively pursued using
MS/MS data acquired with ion trap instruments, which
are the workhorses of many proteomics workflows.
However, the relatively poor mass resolution, mass accu-
racy, and signal-to-noise ratio of ion trap MS/MS data is
a large challenge for de novo sequencing. The basic idea
of de novo sequencing is that, if the mass difference
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between two mass spectral peaks corresponds to an
amino acid mass, the two peaks are likely two adjacent
fragment ions flanking a residue of the peptide. Because
of the low mass accuracy of ion trap MS/MS data, it is
common for two unrelated peaks to have a mass differ-
ence reasonably close to an amino acid mass by coinci-
dence. Additionally, in ion trap tandem mass spectra,
low-intensity peaks of real fragment ions are often
obscured by a large number of noise peaks, again inter-
fering with de novo sequencing.
In recent years, new hybrid mass spectrometers, such
as LTQ-Orbitrap and LTQ-FT from Thermo Fisher
Scientific Inc., have become more common in proteo-
mics workflows [15-17]. These instruments combine the
all-around MS/MS capability of ion trap with the excel-
lent mass analysis capability of Orbitrap and FT-ICR.
Typical proteomics measurements take high-resolution
full scans with Orbitrap or FT-ICR and MS/MS scans
with ion trap to achieve accurate parent mass analysis
and fast MS/MS acquisition. These hybrid instruments
are also capable of acquiring high-resolution tandem
mass spectra by performing peptide fragmentation in
the front-end ion trap and then transferring fragment
ions to the back-end Orbitrap or FT-ICR for mass ana-
lysis. Such high-resolution MS/MS data is more amen-
able to de novo sequencing than MS/MS data acquired
on conventional ion trap instruments. Several de novo
sequencing algorithms, including PepNovo [5,18], Direc-
Tag [13], PEAKS [6] and MSNovo [11], accept both ion
trap MS/MS data and high-resolution MS/MS data.
Most of existing de novo sequencing algorithms can be
adapted to high-resolution MS/MS data by tightening
up mass error tolerance. De novo sequencing has also
been combined with a UStag approach for PTM identifi-
cation using FT-Orbitrap MS/MS data [12,19]. All these
algorithms should obtain a significant performance
boost by using high-resolution MS/MS data.
Here, we report a new de novo sequencing algorithm,
Vonode (Freely available at http://compbio.ornl.gov/
Vonode), to further exploit the potential of high-resolu-
tion MS/MS data by using a unique tag scoring function
and a novel type of spectrum graphs. The scoring func-
tion of Vonode relies more on mass accuracy informa-
tion than on ion intensity information for scoring
sequence tags. Because of the improved dynamic range
and sensitivity of high-resolution MS/MS data, fragment
ions with lower intensity could just as likely be y and b
ions as those with higher intensity. This is contrary to
the intuitive assumption that lower-intensity peaks are
less significant. A rigorous way for using intensity infor-
mation is to model theoretical intensities in a spectrum
for a sequence tag, which in turn requires building a
reliable statistical model with comparable training data
[5]. In comparison, mass accuracy information in high-
resolution MS/MS can be well defined statistically and
is straightforward to use for scoring.
To find sequence tags, many existing de novo sequen-
cing algorithms reconstruct spectrum graphs [20] where
only adjacent fragment ions of the same ion type are
connected. Artifact vertices are used to represent non-
existent complementary ions for lone y or b ions such
that adjacent fragment ions of different ion types can be
connected. Vonode uses a new type of spectrum graph
where every observed product ion is transformed to one
and only one vertex and four types of edges are used to
represent the four possible relationships among adjacent
fragment ions. Although this new type of spectrum
graphs makes it algorithmically more difficulty to find
sequence tags, it allows scoring of sequence tags based
only on the ions observed in a mass spectrum.
Vonode was compared to an established de novo
sequence algorithm, PepNovo v2.0 [5,18], to test
whether these new features improves de novo sequen-
cing. PepNovo v2.0 was adapted to high-resolution MS/
MS data acquired on an LTQ-FT instrument and its
performance was shown to be significantly improved
[18]. This makes PepNovo v2.0 directly comparable to
Vonode. The de novo sequencing performance was
benchmarked with 40,297 high-resolution tandem mass
spectra acquired from a 24-hour shotgun proteomics
measurement of a bacterium Rhodopseudomonas palus-
tris. Peptide sequences were first identified for this MS/
MS dataset with the Sequest-DTASelect toolchain
[1,21]. To further reduce the false discovery rate of data-
base searching, peptide identifications were filtered with
parent mass accuracy using a new Perl program, called
SQAMA (SQt Accurate Mass Annotator). A total of
14,907 spectra were identified with a false discovery rate
of 0.09%. These confident peptide identifications were
used to verify sequence tags generated by de novo
sequencing algorithms. From this benchmark dataset,
the Vonode algorithm inferred sequence tags for 11,422
spectra at an average length of 5.5 residues using the
consensus sequence tag approach. The accuracy of
inferred consensus sequence tags was 84%. In compari-
son, the PepNovo v2.0 algorithm generated sequence
tags for 2,573 spectra with an average length of 6.0 resi-
dues using a score cutoff of 0.8. The accuracy of top
sequence tags from PepNovo v2.0 was 65%. Note that
Vonode cannot be compared to a new version of Pep-
Novo, PepNovo+ [22,23], for high-resolution MS/MS
data, because so far PepNovo+ has only one model for
low-resolution ion trap MS/MS data. Although many
other de novo sequencing algorithms [4,6,11-14] are
available for additional performance benchmarking, the
comparison of Vonode to the established and widely-
used PepNovo v.2.0 program showed that algorithmic
concepts behind Vonode’s scoring function and the new
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type of spectrum graphs are important for de novo
sequencing to take full advantage of high-resolution
MS/MS data.
Methods
Algorithm Description
In an MS/MS measurement, a peptide is isolated by its
m/z and fragmented with collision-induced dissociation.
The product ions are then analyzed using an MS2 scan.
Most high-abundance product ions are y-ion type or
b-ion type, generated from cleavage of peptide bonds.
B-ions are fragments on the N-terminal side and num-
bered as b1, b2 and so on according to the number of
residues they contain. Y-ions are fragments on the
C-terminal side and similarly numbered as y1, y2 and so
on. Other product ions can form directly from the clea-
vage of other bonds or indirectly from secondary frag-
mentation (neutral loss) of primary product ions.
Besides product ions’ peaks, tandem mass spectra are
also populated with noise peaks.
Formally, let us define a tandem mass spectrum with a
neutral parent ion mass P, a mass array {m0, m1, m2, ...,
mn in ascending order and a corresponding relative
abundance array {a0, a1, a2, ..., an. The mass-abundance
pair (m0, a0) has a mass of zero and a relative abun-
dance of 100%. All other pairs (mi, ai), 1 ≤ i ≤ n, corre-
spond to neutral monoisotopic masses and relative
abundances of measured product ions. Mass spectral
peaks are deisotoped and assigned a charge state in the
pre-processing step by the Vonode algorithm. Peaks that
fail in deisotoping are removed.
The de novo sequencing problem is to infer partial
sequences of a peptide (sequence tags) from its tandem
mass spectrum. A sequence tag is represented as
MpR1R2...RmMq, where R1R2...Rm is a sequence of amino
acid residues and Mp and Mq are two residual masses to
the two peptide termini. A residue Ri, 1 ≤ i ≤ m, belongs
to an amino acid set A = {A, C, D, E, F, G, H, K, M, N,
P, Q, R, S, T, V, W, J, Y}. Let M(Ω) be the mass for the
amino acid Ω, Ω Î A. Note that two isobaric amino
acids, I and L, are represented with one letter, J, such
that every amino acid in set A has a unique mass.
Sequence tags are bidirectional in that MpR1R2...RmMq
is equivalent to MqRmRm-1...R1Mp. A sequence tag for a
tandem mass spectrum is considered correct, if the
sequence tag, in either direction, matches exactly a por-
tion of the peptide sequence.
Given multiple sequence tags inferred for a tandem
mass spectrum, a longer sequence tag is more informa-
tive and, at the same time, more likely to be incorrect as
the result of incorporation of a residue with wrong
amino acid assignment. Generally, de novo sequencing
algorithms attempts to find the longest sequence tag
that is correct for a certain probability. The Vonode
algorithm finds optimum sequence tags in four steps:
(1) spectrum graph construction, (2) sequence graph
construction, (3) sequence tag searching, and (4)
sequence tag scoring.
Step 1: Spectrum graph construction
A spectrum graph is constructed from a tandem mass
spectrum, given the amino acid set A. A vertex in the
spectrum graph, vi, represents a product ion (mi, ai), 0 ≤
i ≤ n. Four types of edges are constructed in a spectrum
graph, namely arrow edges, forward-slash edges, back-
slash edges, and vertical-bar edges. Figure 1 illustrates
how edges in the spectrum graph are expected to con-
nect y ions and b ions with one another. Let Ω be an
amino acid (Ω Î A) at the kth residue in a peptide of
length (k + h) residues. This residue is flanked by four
product ions, yh, yh+1, bk-1, and bk. An arrow edge (red
arrows) is expected to connect a y ion (yh) to the next y
ion (yh+1) or a b ion (bk-1) to the next b ion (bk). A for-
ward-slash edge (blue lines) is expected to connect a y
ion (yh) with the next complementary b ion (bk-1). A
backslash edge (green lines) is expected to connect a y
ion (yh+1) with the previous complementary b ion (bk).
A vertical-bar edge (purple lines) is expected to con-
nect two complementary y and b ions (between yh+1
and bk-1 and between yh and bk).
Given a set of vertices with unknown identity in a
spectrum graph, edges are constructed between two ver-
tices using their masses. Let ε be the relative mass error
for an edge, which is the difference between the mea-
sured mass combination of two vertices and the
Figure 1 Model spectrum graph and sequence graph for two
adjacent residues Ω and Ψ. In the spectrum graph, vertices
representing y and b ions are connected by four types of edges:
arrow edges (Red arrows), forward-slash edges (Blue lines), backslash
edges (Green lines), and vertical-bar edges (Purple lines). The
spectrum graph is transformed to a sequence graph, where two
vertices representing residues Ω and Ψ are connected by a
traversable edge (Black solid line).
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expected mass combination given amino acid masses (M
(Ω)) and the parent mass (P). Let Δ be the relative mass
error tolerance (maximum relative mass error allowed).
Two vertices, vi and vj, with respective masses of mi and
mj, 1 ≤ i < j ≤ n and mi < mj, are connected by: (i) an
arrow edge, if | (mj - mi) - M(Ω) | = ε < Δ; (ii) a verti-
cal-bar edge, if | (mj + mi) - P | = ε < Δ; (iii) a forward-
slash edge, if | P - (mj + mi) - M(Ω) | = ε < Δ; and (iv)
a backslash edge, if | (mj + mi) - P - M(Ω) | = ε < Δ.
The relative mass errors of spectrum edges are generally
smaller than the mass errors of ions, because ion in a
spectrum usually have mass errors in the same direction
from out of mass calibration and the mass errors can
cancel part of each other out in the relative mass error
calculation. Figure 2 shows the spectrum graph con-
structed from a tandem mass spectrum of +3 peptide K.
YRPPAESAASGITVR.N. The y and b ions of this pep-
tide could provide information for a sequence tag of
SAASGJT. Two vertices that represent two adjacent y or
b ions measured with sufficient mass accuracy should be
connected by an edge of appropriate type. However, two
vertices that are not related can also be connected from
coincidence of their mass combination. Every edge is
associated with a relative mass error ε and an edge type.
Step 2: Sequence graph construction
A sequence graph is constructed from a spectrum graph
to facilitate sequence tag searching. For clarity, vertices
and edges in a sequence graph are referred to as
Figure 2 Spectrum graph and sequence graph for a measured tandem mass spectrum. Every detected product ion is represented by one
and only one vertex in the spectrum graph. Many isolated vertices that are not connected to other vertices are not shown in the figure. The
spectrum graph is transformed to a sequence graph for sequence tag searching. The orange dotted lines represent short-circuit edges that
prohibit the two connected vertices from being in a sequence path.
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sequence vertices and sequence edges respectively,
whereas vertices and edges in a spectrum graph are
referred to as spectrum vertices and spectrum edges
respectively.
A sequence vertex, representing an amino acid resi-
due, is constructed from interconnected spectrum ver-
tices that correspond to product ions on the two sides
of the residue. These spectrum vertices should be inter-
connected by spectrum edges all labeled with this resi-
due or vertical-bar spectrum edges. In Figure 1,
sequence vertex Ω is constructed from spectrum ver-
tices yh+1, yh, bk-1, and bk and sequence vertex Ψ is con-
structed from spectrum vertices yh-1, yh, bk+1, and bk.
Note that a spectrum vertex can be used for multiple
sequence vertices. A sequence vertex for a residue can
be composed of two to four spectrum vertices with at
least one spectrum vertex from each side of the residue
and a sequence vertex should include as many appropri-
ate spectrum vertices as possible. The sequence graph in
Figure 2 contains sequence vertices that are constructed
from 2, 3 or 4 spectrum vertices. Sequence vertices are
labeled with the m/z values of the included spectrum
vertices.
Any two sequence vertices that share one or more
spectrum vertices are connected by a sequence edge.
There are two types of sequence edges, traversable
edges and short-circuit edges. A traversable sequence
edge (shown as black solid edges in a sequence graph)
connects two sequence vertices whose spectrum vertices
can be fit into the interconnection pattern shown in Fig-
ure 1, allowing for missing spectrum vertices and spec-
trum edges. A sequence edge is a short-circuit edge
(shown as orange dotted edges in a sequence graph), if
it cannot be a traversable edge. Figure 2 illustrates con-
struction of sequence edges in a sequence graph. A tra-
versable sequence edge is used to connect two sequence
vertices whose residues can be placed next to each other
in a sequence tag. A short-circuit edge is used to con-
nect two vertices whose residues cannot be placed in a
sequence tag regardless of whether they are next to each
other or separated by other residues.
Step 3: Sequence tag searching
Potential sequence tags for a tandem mass spectrum are
identified by searching for paths in the sequence graph.
A path in a sequence graph is defined as a sequence of
vertices connected by traversable edges. A valid path is
required to have no repeated vertex or traversable edge
(the simple path rule) and no short-circuit edge
between any two vertices (the short circuit rule). In the
sequence graph of Figure 2, the SAASGJT path and the
SAASGJV path are the two longest valid sequence
paths. The short circuit rule ensures that a path in a
sequence graph corresponds to a legitimate intercon-
nection in the spectrum graph for a sequence tag. An
example of invalid paths is the VJT path in the
sequence graph of Figure 2. This path, corresponding to
an invalid interconnection in the spectrum graph, is
ruled out by the short circuit edge between vertices V
and T in the sequence graph.
There are many possible paths in a non-trivial
sequence graph. The constraint of short-circuit edges
for valid paths may complicate using the dynamic pro-
gramming algorithm described previously for de novo
sequencing [3,5,24]. To identify optimum paths, the
Vonode algorithm uses a brute-force enumeration
approach that simply finds all possible paths for subse-
quent evaluation with a scoring function. Compared to
an analytical approach for finding optimum paths, the
enumeration approach gives the flexibility to use vir-
tually any scoring function and allows identification of
not only the optimum path with the highest score, but
also other top paths that rank below the optimum path.
Path enumeration is efficient for sequence graphs
because of the limited number of vertices and a low
degree of connectivity in sequence graphs. All possible
paths in a sequence graph are found by iterating
through every pair of vertices and identifying all possible
paths between them. Let v and d be two vertices. Find-
Path (v, d, V, P) is a recursive function that finds all
possible paths between v and d and returns them in a
path list P. V is a temporary vertex list for storing ver-
tices to be used to construct a path. P and V are passed
by reference between recursive function calls to save
previous calculation results. Below is the pseudo-code
for FindPath:
FindPath (v, d, V, P)
1. If any two vertices in V are connected by a short-
circuit edge
2. Return
3. Push v onto the back of V
4. If v and d are different vertices
5. For every vertex, v’, that is connected to v by a
traversable edge and is not in V
6. FindPath(v’, d, V, P)
7. Else
8. Construct a path from V and save the path into
P
9. Pop v out of the back of V
10. Return
All legitimate paths between a source vertex s and a
destination vertex d are found with the functional call
FindPath(s, d, j, j), i.e., V and P are empty lists (j) in
the beginning. Some sequence graphs can be divided
into connected components. A connected component is
defined as a maximal subgraph connected by traversable
edges. For these sequence graphs, sequence paths from
each component are found and evaluated independently
of paths in other components.
Pan et al. BMC Bioinformatics 2010, 11:118
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Step 4: Sequence tag scoring
Top sequence tags for a tandem mass spectrum are
identified by scoring and ranking all valid paths in the
sequence graph. The score function used by the Vonode
algorithm is based on mass accuracy information of pro-
duct ions measured in the tandem mass spectrum. In
the step of spectrum graph construction, every spectrum
edge is assigned with a relative mass error, which is
required to be less than the error tolerance (Δ). The
relative mass error is standardized to an edge weight by
the function, ω = 2(1 - pnorm(ε, 0, Δ/2)), where ε
represents the relative mass error variable and ω repre-
sents the edge weight variable. The function, pnorm(ε,
0, Δ/2), calculates the lower-tail cumulative probability
for the variable ε from a normal distribution function
with a mean of 0 and a standard deviation of Δ/2.
Because the relative mass error has a range of [0, Δ],
the standardization assigns every spectrum edge a
weight between 0.05 and 1.00. The larger the relative
mass error of a spectrum edge is, the less weight the
spectrum edge has.
A sequence path is scored by enumerating all spec-
trum edges that are covered by the sequence path. The
score of a sequence path is simply the sum of the
weights of all covered spectrum edges. The top-scoring
sequence paths in a sequence graph are those that cover
many spectrum edges with low relative mass errors. The
top three sequence paths in Figure 2 are SAASGJT
(score = 12.8), AASGJT (score = 12.2), and ASGJT
(score = 11.6).
Given a large set of tandem mass spectra, the Vonode
algorithm attempts de novo sequencing for all tandem
mass spectra and then filters tandem mass spectra based
on the score of the top sequence tag. The default score
cutoff is 4.0.
Proteome sample preparation
R. palustris CGA010 strain was grown in defined growth
medium to mid-log phase. Cells were harvested and
lysed by sonication in ice-cold wash buffer. Cell lysates
were then treated with 6 M guanidine and 10 mM
dithiothreitol (DTT) (Sigma Chemical Co. St. Louis,
MO) at 60°C for 1 hour for protein denaturation and
disulfide bond reduction. After six-fold dilution with 50
mM Tris-HCl/10 mM CaCl2 (pH 7.8), the proteome
sample was digested at 37°C with sequencing grade tryp-
sin (Promega, Madison, WI). The sample was finally
reduced with 20 mM DTT for 1 hour at 60°C and
desalted using C18 solid-phase extraction (Sep-Pak Plus,
Waters, Milford, MA).
LC-MS/MS analysis
The processed proteome sample was examined with a
24-hour two-dimensional liquid chromatography-
tandem mass spectrometry analysis (2D LC-MS/MS) as
described previously [25-27]. Briefly, the sample was
first separated by twelve-step strong cation ion exchange
liquid chromatography and then by continuous gradient
reverse phase liquid chromatography. Eluted peptides
were electrosprayed at 3.6-kV distal electrospray voltage
into an LTQ-Orbitrap mass spectrometer (Thermo
Fisher Scientific, San Jose, CA). Tandem mass spectro-
metry analysis was performed with each full scan (400-
1700 m/z) followed by five data-dependent MS/MS
scans at 35% normalized collision energy. Dynamic
exclusion was enabled. The full scans were acquired
with 2-microscan averaging at resolution 30,000, AGC
target 500,000, and maximum ion injection time 500
ms. The MS/MS scans were acquired with 2-microscan
averaging at resolution 7,500, AGC target 200,000, and
maximum ion time 1,000 ms.
MS/MS data extraction
The proprietary Finnigan RAW files were converted to
FT1 files and FT2 files with a Visual Basic program
called RAW2FT2. The RAW2FT2 program requires Fin-
nigan XDK 2.0 to run. The FT1 and FT2 file formats
are simple extensions of the MS1 and MS2 file formats
[28], respectively, for high-resolution data. In MS1 and
MS2 files, every mass spectrum is represented with two
columns of data for m/z and intensity. In FT1 and FT2
files, every mass spectrum is represented with seven col-
umns of data in the order of m/z, intensity, resolution,
background, noise, and charge state, all of which are
extracted from RAW files. All tandem mass spectra
have header information for monoisotopic parent mass
and charge state in FT2 files. MS/MS data from other
instrument venders need to be converted to the FT1
and FT2 formats to be analyzed by Vonode.
Accurate parent mass filtering of Sequest identification
All MS/MS scans were searched with the Sequest pro-
gram [1] against a concatenated forward and reverse R.
palustris protein database with common protein con-
taminants (Peptide mass tolerance 3 Da, fragment ion
tolerance 0.5 Da, trypsin cleavage with up to 4 internal
cleavage sites) [29]. Search results were reformatted
from OUT files to SQT files [28]. Parent mass accuracy
of all peptide identifications was calculated with the
SQAMA program in three steps. First, theoretical isoto-
pic distribution of a peptide is calculated using its
amino acid sequence and charge state. Then, observed
isotopic distributions are found within ± 0.05-Da m/z
windows of the expected isotopic peaks in the 6 full
scans surrounding the MS/MS scan. Every isotopic peak
in observed isotopic distributions represents an indepen-
dent mass measurement. Finally, the mass error for a
peptide identification is calculated as an average of all
Pan et al. BMC Bioinformatics 2010, 11:118
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observed isotopic peaks’ mass errors weighted by their
intensities. Mass errors are reported in the original
CalcM+H+ field in the SQT files.
The DTASelect program [21] was used to filter pep-
tide identifications and to assemble peptides into pro-
teins using the following parameters: retaining the
duplicate MS/MS spectra for each peptide sequence
(DTASelect option: -t 0), fully tryptic peptides only,
with a delCN of at least 0.08 and cross-correlation
scores (Xcorrs) of at least 1.8 (+1), 2.5 (+2), and 3.5
(+3), and a minimum of two identified peptides for a
protein. Identified peptides were further filtered by their
parent mass errors calculated by SQAMA. Parent mass
errors were normalized by shifting the median of the
mass error distribution to zero for systematic mass error
correction. Only peptide identifications with a normal-
ized parent mass error less than 0.02 Da were retained
as confident peptide identifications. False discovery rates
of peptide identification were calculated using the num-
ber of peptide identifications from reverse protein
sequences.
Performance benchmarking
The FT2 files of the benchmark dataset were input into
the Vonode program for de novo sequencing with the
following parameters: Relative mass error tolerance (Δ,
as defined in the ALGORITHM DESCRIPTION section)
= 0.01 Da; Minimum sequence tag length = 3 (To
require at least 3 residues in a sequence tag).
For performance comparison, the benchmark dataset
was also analyzed with the PepNovo v2.0 program. MS/
MS scans in the FT2 files were formatted into individual
DTA files. The default DTA file format for Sequest has
m/z values with only one digit after the decimal point.
The DTA files generated for PepNovo v2.0 from FT2
files have m/z values with five digits after the decimal
point to represent the high-resolution data and a mea-
sured parent ion charge state. PepNovo was executed
with the default Orbitrap tryptic-peptide model
(LTQ_ORBI_TRYP). PepNovo reports top 20 sequence
tags for every MS/MS scan. The MS/MS scans were fil-
tered by the “Prob” score of the top sequence tag.
Sequence tags inferred by Vonode and PepNovo for a
spectrum were verified with the corresponding Sequest
identification. All data processing was completed on a
Dell Precision 300 workstation with an Intel Core 2
Duo CPU and 2 GB RAM.
Results and Discussion
Orbitrap MS/MS measurement and benchmark dataset
preparation
An R. palustris proteome was measured by 2D LC-MS/
MS on an LTQ-Orbitrap instrument in the Orbitrap
MS/MS mode. The 24-hour analysis yielded 40,297
high-resolution MS/MS spectra. At the configuration of
resolution 7500 and 2 microscan averaging, the scanning
speed of Orbitrap MS/MS was approximately 50 scans
per minute. As a comparison, the scanning speed of
LTQ MS/MS (2 microscan averaging) is about 100
scans per minute. The 2-fold decrease in scanning speed
of Orbitrap MS/MS reduced the number of MS/MS
spectra acquired in the 24-hour 2D LC-MS/MS analysis.
Figure 3 shows the distribution of relative mass errors
between adjacent fragment ions in tandem mass spectra
from the Orbitrap MS/MS benchmark dataset. For com-
parison, a distribution of relative mass errors from an
LTQ MS/MS dataset was shown in Additional File 1,
Figure S1. This indicates that Orbitrap MS/MS achieves
much higher mass accuracy at the expense of a lower
scanning speed.
To benchmark de novo sequencing accuracy, peptide
identifications were first obtained from this R. palustris
dataset using database searching and parent mass accu-
racy filtering. Concatenated forward and reverse data-
base was used to measure false discovery rate of peptide
identification [30]. Sequest identifications were assigned
to 15,308 tandem mass spectra using default DTASelect
filtering criteria yielding a false discovery rate of 0.21%.
Further filtering with parent mass accuracy using the
SQAMA program yielded identifications for 14,907
spectra with a false discovery rate of 0.09%. In this
Figure 3 Distribution of relative mass errors in the Orbitrap
MS/MS benchmark dataset. The relative mass error of a spectrum
edge is the mass error of a fragment ion relative to another
fragment ion given their expected relationship represented by the
spectrum edge. The majority of relative mass errors are distributed
between -0.01 Da and 0.01 Da in the benchmark dataset.
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study, we consider these identifications as gold standard
and use them to verify sequence tags inferred by de
novo sequencing algorithms.
De novo sequencing with the Vonode algorithm
All 40,297 MS/MS spectra were analyzed by the Vonode
algorithm in less than 15 minutes. The de novo sequen-
cing results were evaluated using the top sequence tag
of a spectrum. 14,264 sequenced spectra passed the
score threshold of 4.0, yielding sequence tags with an
average length of 5.5 residues (Additional File 2, Table
S1). For illustration, the de novo sequencing and verifi-
cation results for spectra 1616 - 1644 in cycle 8 are
shown in Table 1. 9 spectra in this scan range have a
sequence tag assignment, which consists of a sequence
tag and two residual masses from the tag to the two ter-
mini of the peptide. The two directions of a sequence
tag (from left to right or from right to left) are equiva-
lent. Isobaric amino acids L and I are not distinguished
in de novo sequencing and they are represented by one
letter, J, for convenience. Eight of these spectra have
Sequest identifications, which were matched to their
sequence tags. The sequence tag of a spectrum is veri-
fied by Sequest to be correct if the sequence tag in one
of the two directions matches exactly to the Sequest
peptide sequence. This criterion of verifying a spec-
trum’s sequence tag assignment is more stringent than
some of those used in previous studies [5,6,9,14,18,24]
in that a spectrum can provide only one sequence tag
(the top sequence tag) for verification and only an exact
match of all residues in a sequence tag to the corre-
sponding peptide sequence can be considered as correct.
A global view of the de novo sequencing and verification
results is shown with a Venn diagram in Figure 4A. The
universal set of all 40,297 spectra is represented by the
outer rectangle. The set of 14,907 spectra that have a
confident Sequest identification is represented by the
circle in the left side. The set of 14,264 spectra that
have the top sequence tag assignment by Vonode is
represented by the circle in the right side. Note that the
Sequest set and the Vonode set do not completely over-
lap. There is a set of 6,136 Sequest-only spectra that
have a Sequest identification but no Vonode sequence
tag assignment. De novo sequencing requires measure-
ment of fragmentation at more than 4 consecutive pep-
tide bonds for inferring a sequence tag with a minimum
length of 3 residues. While fragmentation in these spec-
tra could be informative for Sequest identification, it
may not be contiguous for de novo sequencing with
Vonode.
The intersection of the Sequest set and the Vonode
set represents the 8,771 spectra that have both a Sequest
identification and a sequence tag assignment. Eight
spectra listed in Table 1 belong to this category. As
shown in Table 1, this set of spectra can be further
divided into two categories - correctly sequenced spectra
and incorrectly sequenced spectra - based on the verifi-
cation result. The accuracy of de novo sequencing is
defined as the percentage of the correctly sequenced
spectra in the intersection set. The accuracy of the top
sequence tag assignment is 72% with 6,294 correctly
sequenced spectra and 2,477 incorrectly sequenced spec-
tra. Common types of errors in the incorrect sequence
tags are described in the last section.
Finally, there is a set of 5,493 Vonode-only spectra
that have a sequence tag assignment but no Sequest
identification. If we assume that the de novo sequencing
accuracy calculated from the intersection spectra set
remains approximately the same for the Vonode-only
spectra set, the majority of these sequence tags would
provide correct partial sequence information for many
unidentified peptides in the sample. These unidentified
peptides could be peptides with non-specific cleavages,
peptides whose sequences are not in the protein
sequence database (amino acid polymorphisms or novel
proteins) or peptides with chemical modifications
Table 1 Sample results of de novo sequencing and verification
Scan # De novo Sequencing Verification
Residual Mass Tag Sequence* Residual Mass Score Tag Validity Sequest Identification*
1616 1001.540 APAJG 146.112 8.7 Correct K.RVFNVLTGDAPAIGK.V
1629 1069.550 VJCJQPK 44.049 5.3 N/A N/A
1630 897.447 QEKEVAAVJ 128.105 14.8 Incorrect K.KLVAAVEKEGAGFDLGAYR.D
1635 980.533 EJVQ 146.109 5.3 Incorrect K.MIHFVPRDNIVQK.A
1636 358.233 DGJMVJA 137.071 22.1 Correct R.HALVMLGDALR.H
1640 1219.610 TSSMG 589.296 7.6 Correct R.NYAQLGMSSTPFYQSHGVASK.S
1641 830.437 TJFGA 146.113 11.5 Correct K.IFTTRPDTLFGAK.F
1643 888.524 AGDGAK 147.079 10.4 Correct R.FKAGDGAIVNGIAFR.S
1644 128.096 JFDVJA 271.174 19.3 Correct K.KLFDVLAPR.Y
*Matched sections between the sequence tags and the Sequest identifications are underlined.
*Letter J represents amino acids L or I.
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(biological post-translational modifications or artifact
modifications from sample preparation). The potential
for mining out biological information from these
unidentified peptides is precisely the motivation for
developing the de novo sequencing approach that com-
plements the database searching approach.
Algorithm performance comparison
In this study, three figures of merit were used to evalu-
ate the performance of the de novo sequencing algo-
rithms. The first figure of merit is the accuracy as
defined above. It is calculated from the intersection
spectra as a simple estimate of the probability for a
sequence tag assignment to be correct. The second fig-
ure of merit is the average length of sequence tags
inferred from a benchmark dataset. A longer sequence
tag is more informative and also more likely to be incor-
rect. Given the same accuracy, an algorithm that has lar-
ger average tag length is considered to be better. The
third figure of merit is the number of spectra that an
algorithm can assign a sequence tag to in a benchmark
dataset. A larger percentage of sequenced spectra from
a shotgun proteomics measurement can provide higher
proteome coverage and higher average protein sequence
coverage. The de novo sequencing performance of
Vonode was evaluated using the three figures of merit
at varying score thresholds and a constant minimum tag
length threshold of three residues (Figure 5A). The fig-
ures of merit for the top sequence tag result filtered
with the score thresholds of 4.0 and 8.0 are also shown
in Table 2. By increasing the score threshold for filtering
sequence tags, the accuracy and the average tag length
were improved at the expense of greatly reduced num-
ber of de novo sequenced spectra.
The performance of Vonode was compared to the
PepNovo v2.0 algorithm using the three figures of mer-
its at varying score thresholds (Figure 5). The PepNovo
performance using thresholds of 0.8 and 0.9 are also
shown in Table 2. The Vonode results filtered at thresh-
old 8.0 have approximately the same average tag length
as the PepNovo results. The accuracy of Vonode is bet-
ter than PepNovo with either cutoff. More importantly,
Vonode generated a much larger number of sequence
tags than PepNovo from the same benchmark dataset.
The performance of Vonode and PepNovo was also
compared at different charge states. Spectra were
grouped by parent ion charge states (Z = +1, Z = +2,
and Z ≥ +3) and the performance was evaluated for
each charge state group separately. Vonode performed
equally well for charge state +2 and charge states +3
and higher, but much worse for charge state +1 (Addi-
tional File 3, Figure S2, Part A). PepNovo performed
much better for charge state +2 than other charge states
(Additional File 3, Figure S2, Part B). Vonode and
Figure 4 Overview of the de novo sequencing and verification
results. Spectra are categorized into Sequest-only (SO) spectral set,
Vonode-only (VO) spectral set, and the intersection set. The
intersection set is further divided into correctly sequenced (CS)
spectral set and incorrectly sequenced (IS) spectral set. Each spectral
set is labeled with the number of spectra it contains. (A) Venn
diagram for the top sequence tag results. (B) Venn diagram for the
consensus sequence tag results.
Pan et al. BMC Bioinformatics 2010, 11:118
http://www.biomedcentral.com/1471-2105/11/118
Page 9 of 14
Figure 5 De novo sequencing performance comparison of Vonode and PepNovo using varying score thresholds. The performance is
analyzed for Vonode top sequence tags (A), PepNovo top sequence tags (B), Vonode consensus sequence tags (C), and PepNovo consensus
sequence tags (D). The thresholds are 1, 2, ..., 15 for Vonode and 0.50, 0.55, ..., 1.00 for PepNovo. The performance at each threshold is defined by
the number of sequence spectra (x-axis), the accuracy (y-axis), and the average tag length (text labels of the data points).
Table 2 Comparison of de novo sequencing performance
Algorithm Threshold Sequence Tag Intersection Spectra Accuracy Average Tag Length Sequenced Spectra
Vonode 8.0 Top 4897 75% 6.2 7142
4.0 Top 8771 72% 5.5 14264
4.0 Consensus 7220 84% 5.0 11422
PepNovo 0.9 Top 1293 70% 6.0 1821
0.8 Top 2460 65% 6.0 3716
0.8 Consensus 2160 78% 4.7 3253
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PepNovo had a similar performance for charge state +2,
but Vonode outperformed PepNovo in the other two
charge state groups. The de novo sequencing perfor-
mance of Vonode and PepNovo was also compared at
different ranges of mass coverage. Mass coverage is
defined for a spectrum as the percentage of the parent
peptide mass explained by a sequence tag. Mass cover-
age was designed to normalize the sequence tag size
using the parent peptide size. Performance of Vonode
and PepNovo was compared in three mass coverage
ranges: 0% ~20%, 20% ~40%, and 40% ~100% (Addi-
tional File 4, Figure S3). In the 0% ~20% range, Vonode
produced shorter sequence tags at higher accuracy from
more spectra than PepNovo. In the other two mass cov-
erage ranges, Vonode sequenced more spectra than Pep-
Novo at comparable average tag length and accuracy.
The superior performance of Vonode is attributed to
two key algorithmic innovations. First, a new type of
spectrum graph was developed for sequence tag evalua-
tion. Spectrum graphs were first proposed by Bartels et
al [20] and have been used in many de novo sequencing
algorithms. In the Bartels type of spectrum graphs, only
one type of edge is used, which connects adjacent frag-
ment ions of the same ion type. Artifact vertices are cre-
ated to represent absent complementary ions for a lone
y or b ion to capture the relationships between adjacent
fragment ions of different ion types via those artifact
vertices. In this study, a new type of spectrum graph
was developed to use four types of edges to represent
the four possible relationships among adjacent fragment
ions (Figures 1 and 2), avoiding creation of any artifact
vertices. Every observed product ion is transformed to
one and only one vertex in spectrum graph. The score
for a sequence tag is the total weight of all spectrum
edges covered by the sequence tag. This scoring func-
tion rewards a fragmentation site defined by a pair of
complementary y and b ions much more than one
defined by a lone y or b ion. A residue derived from
two adjacent pairs of complementary y and b ions is
rewarded with the total weight of six spectrum edges;
whereas a residue derived from two adjacent lone frag-
ment ions is rewarded with the weight of only one spec-
trum edge (Figures 1 and 2).
Second, the weight of a spectrum edge is calculated
based on its relative mass error without using intensity
information. False edges connecting two unrelated ions
were expected to be more likely to have a high relative
mass error than true edges connecting two y or b ions.
Based on the distribution of relative mass errors in the
benchmark dataset (Figure 3), the relative mass error of
a spectrum edge was standardized to a weight between
0 and 1. Higher edge weights correspond to lower rela-
tive mass errors. This simplistic scoring function of
weighing spectrum edges with relative mass errors was
designed to take advantage of the improved mass accu-
racy, sensitivity, and dynamic range of Orbitrap and FT-
ICR mass analyzers.
Development of consensus sequence tag approach
If the top sequence tag of a spectrum is incorrect, the
sequence tag with the second highest score for this
spectrum could be correct. One can use the top two
sequence tags of a spectrum to match its Sequest identi-
fication and consider this spectrum to be correctly
sequenced if one of the top two sequence tags matches
the Sequest identification. The accuracy of the top
sequence tags at threshold 4.0 was 72%. By adding the
second best sequence tag of every spectrum into consid-
eration, the accuracy was improved to 82%. Adding the
third best tag increased the accuracy further to 86%.
There was a diminishing return on the accuracy
improvement by including more lower-ranking sequence
tags. Considering multiple top ranking sequence tags for
a spectrum conveniently improved the accuracy, but it
would also complicate the subsequent step of using
sequence tags for sequence polymorphism characteriza-
tion and chemical modification identification. A consen-
sus sequence tag approach was proposed to obtain the
significant accuracy gain of including the second best
sequence tag without reporting two sequence tags for a
spectrum. A consensus sequence tag is simply the maxi-
mum common sub-sequence between the top two
sequence tags in a spectrum. It is guaranteed to be cor-
rect if at least one of the top two sequence tags is
correct.
The Vonode de novo sequencing results were analyzed
with the consensus sequence tag approach at varying
score thresholds (Figure 5C). Consensus sequence tags
were obtained from 11422 spectra using a score thresh-
old of 4.0 and a minimum tag length of three residues
(Figure 4B and Additional File 5, Table S2). Figures of
merit of this consensus sequence tags approach are
shown in Table 2. The consensus tag of a spectrum is at
least one residue shorter than the top sequence tag. A
spectrum with a consensus sequence tag shorter than 3
residues was discarded. Consensus sequence tags were
also extracted from the PepNovo results using varying
score thresholds (Figure 5D). The performance of the
consensus sequence tag approach was compared to the
top sequence tag approach for both Vonode and Pep-
Novo at different charge states and different mass cover-
age ranges (Additional Files 3, Figure S2, and Additional
File 4, Figure S3). Compared to top sequence tags, con-
sensus sequence tags have a greatly improved accuracy
at the expense of reduced total number of sequenced
spectra and lower average tag length (Table 2). Top
sequence tags from Vonode and PepNovo are generally
extensions of lower scoring tags or differ from lower
Pan et al. BMC Bioinformatics 2010, 11:118
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scoring tags only in the end residues (Additional File 2,
Table S1) and taking consensus sequence tags has the
effect of trimming off unreliable residues from the ends
of top sequence tags. We think that the consensus
sequence tag approach is a better balance among the
three figures of merit (the accuracy, the total number of
sequenced spectra, and the average tag length) than the
top sequence tag approach.
Characterization of de novo sequencing errors
1190 consensus sequence tags and 2477 top sequence
tags failed to match Sequest identifications in the incor-
rectly sequenced spectral set (Figure 4). The majority of
these sequence tags are different from the corresponding
Sequest identifications by one or two residues. The
errors in those incorrect sequence tags are not random
amino acid substitutions from their Sequest identifica-
tions. There were substitution errors that occur rarely,
such as the substitution between two nearly isobaric
amino acids, Q and K. The masses of amino acids Q
and K are different by only 0.036 Da. With ion trap
MS/MS data, it is almost impossible to resolve such a
small mass difference to distinguish these two amino
acids. In this Orbitrap MS/MS dataset, there were only
0.3% of incorrect sequence tags (3 consensus sequence
tags and 7 top sequence tags) that had the substitution
error between amino acids Q and K.
Five common types of minor errors by Vonode were
characterized (Table 3). An incorrect sequence tag is
categorized into one of the five error types if it can be
corrected by making a single sequence change of that
type. Many wrong sequence tags could be corrected by
substituting an amino acid Q with two amino acids G
and A (Table 3). An example for this error type is the
incorrect sequence tag for spectrum 1630 in Table 1.
The combined mass of G and A is exactly the same as
the mass of Q. When the fragment ions between G and
A are missing in a spectrum, the residue doublets, GA
or AG, would be mistakenly replaced by a single residue
of Q in the sequence tag. In this benchmark dataset, a
residue Q in a sequence tag has an approximately 12%
probability to actually be GA or AG. This probability of
the Q assignment ambiguity should be taken into
account when using a sequence tag containing Q. For
the same reason, the residue doublet, GG, can be mista-
ken for a single residue of N. Together, these two types
of errors account for 18% incorrect consensus sequence
tags and 12% incorrect top sequence tags.
An interesting common type of de novo sequencing
error is the inversion of two adjacent residues (Table 3).
An example of this error type is a spectrum with the
sequence tag of JQJYR and the Sequest identification of
R.FWTDQILYRL.-. The sequence tag would match the
Sequest identification by inversing the two residues Q
and J in bold type. Inversions can involve any combina-
tion of amino acids. The relative order of two adjacent
residues in a sequence tag is determined from fragment
ions between them. It is difficult to explain why two
adjacent residues can be mistakenly inversed so fre-
quently. Note that, even if two adjacent residues in a
peptide are indeed inversed from their order in the
sequence database, Sequest would still likely identify this
peptide as the best match for the spectrum and report
the peptide sequence in the sequence database.
A much larger percentage of incorrect sequence tags
have a single wrong end residue than have a single
wrong internal residue (Table 3). This position-depen-
dent bias arises from Vonode’s tendency to extend a
sequence tag to the longest possible. This improves
average tag length, but makes the end residues far more
likely to be wrong than internal residues. In light of this,
it is recommended that, when matching a sequence tag
to a sequence database, a mismatch at an end residue of
the sequence tag should be considered as a probable de
novo sequencing error.
Together, these five types of minor errors account for
74% of incorrect top sequence tags and 65.5% of incor-
rect consensus sequence tags. If all the intersection
spectra are considered, 84% of the consensus sequence
tags match Sequest identifications exactly, 10.5% of
them mismatch due to one of these minor errors, and
only 5.5% of them mismatch due to other types of
errors. Similarly, there are only 5.4% of top sequence
tags from the intersection spectra that mismatch
Table 3 Characterization of common de novo sequencing errors
De novo sequencing error types Top sequence tags Consensus sequence tags
Counts Percentage Counts Percentage
Substitution of a Q by GA 243 9.8% 174 14.6%
Substitution of an N by GG 51 2.1% 42 3.5%
Inversion of two adjacent residues 222 9.0% 103 8.7%
Subsitution of an end residue 1002 40.5% 421 35.4%
Subsitution of an internal residue 98 4.0% 59 5.0%
Other 861 25.8% 391 32.9%
Total 2477 100.0% 1190 100.0%
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Sequest identifications due to other types of errors.
Therefore, de novo sequencing results should be used
with consideration of these common types of minor
errors.
Conclusion
In this study, a de novo sequencing algorithm, Vonode,
was developed specifically for high-resolution MS/MS
data. Vonode has a unique scoring system that takes
advantage of the excellent mass accuracy, sensitivity,
and dynamic range of Orbitrap and FT-ICR mass ana-
lyzers. The de novo sequencing performance of Vonode
was benchmarked in terms of accuracy, average
sequence tag length, and total number of sequenced
spectra using a 24-hour shotgun proteomics measure-
ment of R. palustris. Using the new consensus
sequence tag approach, 11,422 sequence tags with an
average length of 5.5 were inferred at 84% accuracy
from a total of 40,297 input spectra. This represents a
significant improvement from the established PepNovo
v2.0 algorithm for analyzing high-resolution MS/MS
data.
Obtaining sequence tags is the first step towards iden-
tification of post-translational modifications and amino
acid polymorphisms that may be missed by database
searching algorithms [31,32]. In future work, a separate
algorithm will be developed to use sequence tags to
search a protein sequence database and reconstruct
many candidate peptides by considering a large number
of chemical modifications [33,34] or polymorphisms
[35,36]. To find the most likely modifications or poly-
morphisms, the candidate peptides will be evaluated by
matching their theoretical spectra against the measured
spectrum, which is analogous to the scoring strategy
commonly used by database searching algorithms. In
this two-step approach, a de novo sequencing algorithm
provides short sequence tags to constraint database
searches for modifications or polymorphisms and a
database-searching-like algorithm pinpoints optimum
identifications. We showed here that the Vonode algo-
rithm provides reliable de novo sequencing results from
high-resolution MS/MS data.
Additional file 1: Figure S1, Distribution of relative mass errors in
an LTQ MS/MS dataset. Comparison of distributions of relative mass
errors indicates that Orbitrap MS/MS (Figure 3) provides a much higher
mass accuracy for de novo sequencing than LTQ MS/MS.
Click here for file
[ http://www.biomedcentral.com/content/supplementary/1471-2105-11-
118-S1.PDF ]
Additional file 2: Table S1, Top sequence tags inferred by Vonode
and their verification using Sequest identification results.
Click here for file
[ http://www.biomedcentral.com/content/supplementary/1471-2105-11-
118-S2.XLS ]
Additional file 3: Figure S2, De novo sequencing performance
comparison of Vonode and PepNovo for peptides at different
charge states. The performance is analyzed for Vonode top sequence
tags (A), PepNovo top sequence tags (B), Vonode consensus sequence
tags (C), and PepNovo consensus sequence tags (D) from three different
charge states (the blue curve for +1 peptides, the green curve for +2
peptides, and the red curve for +3 and higher charge state peptide). The
thresholds are 1, 2, ..., 15 for Vonode and 0.50, 0.55, ..., 1.00 for PepNovo.
The performance at each threshold is defined by the number of
sequence spectra (x-axis), the accuracy (y-axis), and the average tag
length (text labels of the data points).
Click here for file
[ http://www.biomedcentral.com/content/supplementary/1471-2105-11-
118-S3.PDF ]
Additional file 4: Figure S3, De novo sequencing performance
comparison of Vonode and PepNovo for sequence tags at different
mass coverages. The performance is analyzed for Vonode top sequence
tags (A), PepNovo top sequence tags (B), Vonode consensus sequence
tags (C), and PepNovo consensus sequence tags (C) from three ranges of
mass coverages (the blue curve for 0% ~20%, the green curve for 20%
~40%, and the red curve for 40% and above). The thresholds are 1, 2, ...,
15 for Vonode and 0.50, 0.55, ..., 1.00 for PepNovo. The performance at
each threshold is defined by the number of sequence spectra (x-axis),
the accuracy (y-axis), and the average tag length (text labels of the data
points).
Click here for file
[ http://www.biomedcentral.com/content/supplementary/1471-2105-11-
118-S4.PDF ]
Additional file 5: Table S2, Consensus sequence tags inferred by
Vonode and their verification using Sequest identification results.
Click here for file
[ http://www.biomedcentral.com/content/supplementary/1471-2105-11-
118-S5.XLS ]
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